Actualités

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Groves facility reaches first criticality in under 11 months.

Moby summary of Oklo Inc.'s Q2 2026 earnings call

Oklo Inc (OKLO) reports a $81.6 million net loss but achieves first criticality at Groves facility and secures key DOE award, positioning for 2028 Aurora startup.

Energy stocks were lower late Friday afternoon, with the NYSE Energy Sector Index falling 1.1% and t

Oklo just posted its first real quarterly revenue and the stock surged, yet shares still sit 33% in the red for the year. A return to triple digits is mathematically possible, but it hinges on a very specific stack of catalysts falling into place.

Oklo achieved a crucial milestone.

Oklo (NYSE:OKLO) shares opened about 7% higher on Friday after the advanced nuclear technology company reported second quarter results that included a wider-than-expected loss but revenue that came in well above analyst estimates. The company reported a loss per share of $0.28, compared with...

Oklo posted revenue of $1.2 million in the second quarter, exceeding Street estimates of around $70,000, according to Fiscal.ai data

The benchmark US stock measures were tracking in the green before the open Friday as traders await a

Nonfarm payrolls fell by 23,000, marking the first monthly decline in employment in years

Oklo (OKLO) just reached first criticality at its Groves low power test reactor in Texas, achieving a controlled, self sustaining nuclear chain reaction less than a year after breaking ground. See our latest analysis for Oklo. Despite the Groves milestone, Oklo’s recent price action has been weak, with the share price down about 46% year to date and the 1 year total shareholder return also declining by about 47%, even after a strong multi year total shareholder return above 300%. If this kind...

With virtually no revenue line to judge, four things decide this report.

High expectations leave little room for disappointment.

Centrus Energy Corp (LEU) reports strong Q2 2026 results with revenue up 14% and a $4.5 billion backlog, driven by key HALEU agreements and a $900 million DOE task order.

Advanced nuclear startup Oklo achieved first criticality at its Groves Isotope Test Reactor in Texas in less than 12 months.

(Bloomberg) -- Oklo Inc.’s small modular reactor has reached a key milestone, the Energy Department announced Thursday.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftMicrosoft’s AI Sales Mostly Come From OpenAI, Disclosures ShowMajor Hedge Funds Targeted in Wave of Attempted CyberattacksWhy Do Data Centers Use So Much Fresh Water?Oklo’s Groves Isotope Test Reactor in Texas reached “criticality,” which occur

As OKLO gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.

A positive update on Oklo's reactor progress could reverse the nuclear stock's downward spiral.

Shares of Oklo have fallen close to 40% this year.

From Berkshire Hathaway to Oklo, there are plenty of ways to construct a diversified energy portfolio with $10,000.

Earnings continue to be the market's engine, and a series of results this week from Palantir, SpaceX, and AMD are set to rev up stocks again.

As SMR gears up to report second-quarter earnings, let's find out how the expectations stack up. Also, know how to play the stock ahead of results.

Oklo could survive an AI bust, but its valuation probably couldn't.

Oklo stock has delivered a very large 5 year gain, yet the latest valuation checks suggest the shares now lean expensive rather than clearly cheap. Oklo has returned 291.8% over 5 years, which makes the recent share price level look demanding for new investors who focus on entry price. The recent U.S. Department of Energy authorization for the Groves isotope reactor can support expectations for commercial isotope revenue. At the same time, execution and regulatory risk around scaling...

Constellation Energy, Constellation Energy stock, CEG stock, nuclear stocks, best nuclear stock

One sells power today with $2B in revenue and major partnerships; the other has zero revenue but billion-dollar customer commitments.

The uranium fund's history of deep dives offers a tough lesson for anyone tempted by the current discount.

The Microsoft co-founder is betting billions on the future of nuclear power.

Advanced nuclear fission developer Oklo (OKLO) reached a major regulatory milestone after receiving official startup authorization from the U.S. Department of Energy (DOE) for its Groves Isotope Test Reactor in Lockhart, Texas. Key Takeaways Oklo received formal U.S. Department of Energy (DOE) authorization to load nuclear fuel and begin startup testing at its Groves reactor [...]